Neuroactive steroids alphaxalone and CDNC24 are effective hypnotics and potentiators of GABAA currents, but are not neurotoxic to the developing rat brain. (May 2020)
- Record Type:
- Journal Article
- Title:
- Neuroactive steroids alphaxalone and CDNC24 are effective hypnotics and potentiators of GABAA currents, but are not neurotoxic to the developing rat brain. (May 2020)
- Main Title:
- Neuroactive steroids alphaxalone and CDNC24 are effective hypnotics and potentiators of GABAA currents, but are not neurotoxic to the developing rat brain
- Authors:
- Tesic, Vesna
Joksimovic, Srdjan M.
Quillinan, Nidia
Krishnan, Kathiresan
Covey, Douglas F.
Todorovic, Slobodan M.
Jevtovic-Todorovic, Vesna - Abstract:
- Abstract: Background: The most currently used general anaesthetics are potent potentiators of γ-aminobutyric acid A (GABAA ) receptors and are invariably neurotoxic during the early stages of brain development in preclinical animal models. As causality between GABAA potentiation and anaesthetic-induced developmental neurotoxicity has not been established, the question remains whether GABAergic activity is crucial for promoting/enhancing neurotoxicity. Using the neurosteroid analogue, (3α, 5α)-3-hydroxy-13, 24-cyclo-18, 21-dinorchol-22-en-24-ol (CDNC24), which potentiates recombinant GABAA receptors, we examined whether this potentiation is the driving force in inducing neurotoxicity during development. Methods: The neurotoxic potential of CDNC24 was examined vis-à-vis propofol (2, 6-diisopropylphenol) and alphaxalone (5α-pregnan-3α-ol-11, 20-dione) at the peak of rat synaptogenesis. In addition to the morphological neurotoxicity studies of the subiculum and medial prefrontal cortex (mPFC), we assessed the extra-, pre-, and postsynaptic effects of these agents on GABAergic neurotransmission in acute subicular slices from rat pups. Results: CDNC24, like alphaxalone and propofol, caused dose-dependent hypnosis in vivo, with a higher therapeutic index. CDNC24 and alphaxalone, unlike propofol, did not cause developmental neuroapoptosis in the subiculum and mPFC. Propofol potentiated post- and extrasynaptic GABAA currents as evidenced by increased spontaneous inhibitoryAbstract: Background: The most currently used general anaesthetics are potent potentiators of γ-aminobutyric acid A (GABAA ) receptors and are invariably neurotoxic during the early stages of brain development in preclinical animal models. As causality between GABAA potentiation and anaesthetic-induced developmental neurotoxicity has not been established, the question remains whether GABAergic activity is crucial for promoting/enhancing neurotoxicity. Using the neurosteroid analogue, (3α, 5α)-3-hydroxy-13, 24-cyclo-18, 21-dinorchol-22-en-24-ol (CDNC24), which potentiates recombinant GABAA receptors, we examined whether this potentiation is the driving force in inducing neurotoxicity during development. Methods: The neurotoxic potential of CDNC24 was examined vis-à-vis propofol (2, 6-diisopropylphenol) and alphaxalone (5α-pregnan-3α-ol-11, 20-dione) at the peak of rat synaptogenesis. In addition to the morphological neurotoxicity studies of the subiculum and medial prefrontal cortex (mPFC), we assessed the extra-, pre-, and postsynaptic effects of these agents on GABAergic neurotransmission in acute subicular slices from rat pups. Results: CDNC24, like alphaxalone and propofol, caused dose-dependent hypnosis in vivo, with a higher therapeutic index. CDNC24 and alphaxalone, unlike propofol, did not cause developmental neuroapoptosis in the subiculum and mPFC. Propofol potentiated post- and extrasynaptic GABAA currents as evidenced by increased spontaneous inhibitory postsynaptic current (sIPSC) decay time and prominent tonic currents, respectively. CDNC24 and alphaxalone had a similar postsynaptic effect, but also displayed a strong presynaptic effect as evidenced by decreased frequency of sIPSCs and induced moderate tonic currents. Conclusions: The lack of neurotoxicity of CDNC24 and alphaxalone may be at least partly related to suppression of presynaptic GABA release in the developing brain. … (more)
- Is Part Of:
- British journal of anaesthesia. Volume 124:Number 5(2020)
- Journal:
- British journal of anaesthesia
- Issue:
- Volume 124:Number 5(2020)
- Issue Display:
- Volume 124, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 124
- Issue:
- 5
- Issue Sort Value:
- 2020-0124-0005-0000
- Page Start:
- 603
- Page End:
- 613
- Publication Date:
- 2020-05
- Subjects:
- general anaesthetic -- prefrontal cortex -- presynaptic -- subiculum -- synaptic transmission -- synaptogenesis
Anesthesiology -- Periodicals
Anesthesia -- Periodicals
617.9605 - Journal URLs:
- http://bja.oupjournals.org ↗
http://bja.oxfordjournals.org ↗
https://www.journals.elsevier.com/british-journal-of-anaesthesia ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.bja.2020.01.013 ↗
- Languages:
- English
- ISSNs:
- 0007-0912
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2303.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13557.xml